Rosa-Molinar receives dual honors from scientific societies
Eduardo Rosa-Molinar, a professor of cell biology and physiology and of neuroscience at WashU Medicine, was recognized by the American Society for Cell Biology and the Histochemical Society for exceptional research and mentorship in imaging science.
Stone awarded $3.7 million to study rare metabolic disorder
Stephen Stone, MD, an assistant professor of pediatrics at WashU Medicine, was awarded a $3.7 million grant from the National Institutes of Health (NIH) to study a genetic condition that causes the body to lose fat in different regions of the body. The disease causes severe insulin resistance, diabetes and high cholesterol.
NIH grant supports study of gut microbes and blood cell production
A collaboration led by WashU Medicine infectious diseases researcher Megan Baldridge, MD, PhD, could lead to new options for vulnerable patients to maintain healthy blood counts.
New discovery may point to clues about how head and neck cancers spread
WashU Medicine faculty and research members of Siteman Cancer Center have identified a previously unknown population of aggressive tumor cells in difficult-to-treat head and neck cancers.
Prize supports hunt for broad-spectrum antivirals
WashU Medicine infectious diseases expert Michael Diamond, MD, PhD, has won a $2.5 million prize to advance the development of drugs to treat debilitating chikungunya and related viruses.
Private equity owns less than 4% of U.S. hospitals, WashU research finds
A new study led by researchers at Olin Business School at Washington University in St. Louis finds private equity only accounts for a small share of the nation’s hospitals, with most investors exiting within five years.
WashU Medicine names new chair of pediatrics
A nationally recognized pediatric endocrinologist, Madhusmita Misra, MD, pioneered research on bone density and metabolic disorders in young women. Her appointment begins Jan. 4.
$11 million grant to investigate why resident microbes go rogue
WashU Medicine researchers have been awarded a nearly $11 million grant from the National Institutes of Health (NIH) to decode how gut bacteria turn hostile, leading to dangerous infections.
Spielman installed as Lauren and Lee Fixel Distinguished Professor
Economist David Spielman brings global expertise in food policy and agricultural innovation to Bursky Public Health, advancing research connecting food systems and health.
Osteoarthritis therapy study advances with $17 million from ARPA-H
The funding will support a WashU Medicine collaboration with CRISPR Therapeutics and SynGenix, a WashU startup, to move a single-injection treatment to reverse joint damage into clinical trials.
Older Stories